Hashim Peter W., Chen Tinley, Rigel Darrell, Bhatia Neal, Kircik Leon H.
J Drugs Dermatol. 2019 May 1;18(5):s161-166..
Actinic keratosis (AK) develops on chronically sun-exposed skin and constitutes one of the most common diseases managed by dermatologists. The incidence of AKs continues to rise among aging as well as younger sun damaged populations worldwide, underscoring the importance of effective therapy options. Various treatments are available, including light-based therapies, topical therapies, and destructive therapies. Herein, we review the current management options for AKs and discuss emerging therapeutic agents. J Drugs Dermatol. 2019;18(5 Suppl 1):s161-166.
光化性角化病(AK)发生于长期暴露于阳光下的皮肤,是皮肤科医生诊治的最常见疾病之一。在全球老龄化人群以及年轻的晒伤人群中,AK的发病率持续上升,这凸显了有效治疗方案的重要性。目前有多种治疗方法可供选择,包括光疗法、局部治疗和破坏性治疗。在此,我们综述了当前AK的治疗方案,并讨论了新兴的治疗药物。《皮肤药物学杂志》。2019年;18(5增刊1):s161 - 166。